The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The Food and Drug Administration and GlaxoSmithKline recently sent notice to healthcare professionals and pharmacists about a new black box warning on Dexedrine (dextroamphetamine sulfate). The drug, typically prescribed to treat Attention-Deficit Hyperactivity Disorder and narcolepsy, has been shown to cause sudden death in association with CNS stimulant treatment in children and adolescents with heart problems.

Comments are closed.

Of Interest